CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Robertson Stephen P. Chief Legal Officer | Sale | −11,939 | $15.95 | $190K | 588,848 |
| 2026-08-21 | Robertson Stephen P. Chief Legal Officer | Sale | −20,975 | $16.97 | $356K | 600,787 |
| 2026-06-04 | Goetz Kathleen Director | Grant or award · Director Stock Option (right to buy) | +23,931 | 23,931 | ||
| 2026-06-04 | Bailey Jeffrey Allen Director | Grant or award · Director Stock Option (right to buy) | +23,931 | 23,931 | ||
| 2026-06-04 | Johnson Craig A Director | Grant or award · Director Stock Option (right to buy) | +23,931 | 23,931 | ||
| 2026-06-04 | Nova Tina Susan Director | Grant or award · Director Stock Option (right to buy) | +23,931 | 23,931 | ||
| 2026-06-02 | TANG KEVIN Chief Executive Officer | Purchase | +206,005 | $15.28 | $3.1M | 13,044,106 |
| 2026-06-02 | TANG KEVIN Chief Executive Officer | Other acquisition · Short Put Options (potential obligation to buy) | +10,000 | $1.65 | $17K | 10,000 |
| 2026-06-01 | TANG KEVIN Chief Executive Officer | Purchase | +343,521 | $15.28 | $5.2M | 12,838,002 |
| 2026-06-01 | TANG KEVIN Chief Executive Officer | Purchase | +99 | $15.34 | $2K | 12,838,101 |
| 2026-05-29 | TANG KEVIN Chief Executive Officer | Purchase | +2,299 | $15.35 | $35K | 12,231,799 |
| 2026-05-29 | TANG KEVIN Chief Executive Officer | Purchase | +262,682 | $15.31 | $4.0M | 12,494,481 |
| 2026-05-18 | Cole Ryan Chief Operating Officer | Grant or award | +116,144 | 116,144 | ||
| 2026-05-18 | Cole Ryan Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +70,230 | 70,230 | ||
| 2026-05-18 | Robertson Stephen P. Chief Legal Officer | Grant or award | +115,541 | 621,402 | ||
| 2026-05-18 | Hearne Michael S Chief Financial Officer | Grant or award | +116,144 | 116,144 | ||
| 2026-05-18 | Hearne Michael S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +70,230 | 70,230 | ||
| 2026-03-06 | Keenan Greg SVP, Chief Medical Officer | Shares withheld for taxes | −8,069 | $14.32 | $116K | 154,449 |
| 2026-03-03 | TANG KEVIN Director | Purchase | +184,208 | $14.22 | $2.6M | 12,229,500 |
| 2026-03-02 | Miller Joseph M Chief Financial Officer | Shares withheld for taxes | −37,511 | $14.21 | $533K | 576,421 |
Page 1 of 10 · 197 trades